Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.92 -0.02 (-1.04%)
As of: Oct 22, 2026 · 12:52 PM EDT

Polaryx Therapeutics (PLYX) Common Equity (2024 - 2026)

Updated

Polaryx Therapeutics (PLYX) recorded Common Equity of $10.94 million in Q2 2026, up 237.0% from $3.25 million a year earlier and up 339.7% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Polaryx Therapeutics reported Common Equity of $4.57 million, down 3.1% from FY2024.

  • Across earlier years, Common Equity came in at $4.71 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn 81.53 Bn
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn -5.94 Bn
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 50.37 Bn
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn 11.83 Bn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn 85.49 Bn
10 Polaryx Therapeutics 92.68 Mn 68.30 Mn - 10.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.94 Mn
Mar 31, 2026 2.49 Mn
Dec 31, 2025 4.57 Mn
Jun 30, 2025 3.25 Mn
Mar 31, 2025 4.25 Mn
Dec 31, 2024 4.71 Mn
API Access

Polaryx Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=PLYX&period=max&api_key=YOUR_API_KEY